The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses

European Journal of Immunology

Volumn 33, Issue 11, 2003, Pages 3186-3195

  Plant, Andrea ^a   Williams, Rachel ^a   Jackson, Michelle E ^a   Williams, Neil A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

EtxB; Immune modulation; Mucosal immunization; Oral tolerance

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; ESCHERICHIA COLI ENTEROTOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BETA CHAIN; CELL DIVISION; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG POTENTIATION; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TH2 CELL; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL TOXINS; CELL DIVISION; CHIMERA; CYTOKINES; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNE TOLERANCE; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; TH2 CELLS;

EID: 0242559044     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324154     Document Type: Article

References (37)

1. Weiner, H. L., Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 1997. 18: 335-343.
2. Bergquist, C., Johansson, E. L., Lagergard, T., Holmgren, J. and Rudin, A., Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 1997. 65: 2676-2684.
3. Akbari, O., Stock, P., DeKruyff, R. H. and Umetsu, D. T., Mucosal tolerance and immunity: regulating the development of allergic disease and asthma. Int. Arch. Allergy Immunol. 2003. 130: 108-118.
4. Macpherson, A., Khoo, U. Y., Forgacs, I., Philpott-Howard, J. and Bjarnason, I., Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996. 38: 365-375.
5. Elson, C. O. and Ealding, W., Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 1984. 132: 2736-2741.
6. Spangler, B. D., Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992. 56: 622-647.
7. Elson, C. O. and Ealding, W., Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 1984. 133: 2892-2897.
8. Clements, J. D., Hartzog, N. M. and Lyon, F. L., Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988. 6: 269-277.
9. Lycke, N., Tsuji, T. and Holmgren, J., The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 1992. 22: 2277-2281.
10. Di Tommaso, A., Saletti, G., Pizza, M., Rappuoli, R., Dougan, G., Abrignani, S., Douce, G. and De Magistris, M. T., Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 1996. 64: 974-979.
11. Richards, C. M., Shimeld, C., Williams, N. A. and Hill, T. J., Induction of mucosal immunity against herpes simplex virus type 1 in the mouse protects against ocular infection and establishment of latency. J. Infect, Dis. 1998. 177: 1451-1457.
12. Richards, C. M., Aman, A. T., Hirst, T. R., Hill, T. J. and Williams, N. A., Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 2001. 75: 1664-1671.
13. Gagliardi, M. C., Sallusto, F., Marinaro, M., Langenkamp, A., Lanzavecchia, A. and De Magistris, M. T., Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 2000. 30: 2394-2403.
14. Turcanu, V., Hirst, T. R. and Williams, N. A., Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. Immunology 2002. 106: 316-325.
15. Braun, M. C., He, J., Wu, C. Y. and Kelsall, B. L., Cholera toxin suppresses interleulkin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J. Exp. Med. 1999. 189: 541-552.
16. Ryan, E. J., McNeela, E., Pizza, M., Rappuoli, R., O'Neill, L. and Mills, K. H., Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. J. Immunol. 2000. 165: 5750-5759.
17. Nashar, T. O., Hirst, T. R. and Williams, N. A., Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, 137, CD40, CD25 and ICAM-1. Immunology 1997. 91: 572-578.
18. Kim, P. H., Eckmann, L., Lee, W. J., Han, W. and Kagnoff, M. F., Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1. J. Immunol. 1998. 160: 1198-1203.
19. + regulatory T-cells. Diabetes 1999. 48: 2150-2156.
20. + T cells. Arthritis Rheum. 2002. 46: 1671-1682.
21. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K., Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994. 1: 327-339.
22. Cheng, E., Cardenas-Freytag, L. and Clements, J. D., The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine 1999. 18: 38-49.
23. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994. 265: 1237-1240.
24. Kuhn, R., Rajewsky, K. and Muller, W., Generation and analysis of interleukin-4 deficient mice. Science 1991. 254: 707-710.
25. Sonoda, E., Matsumoto, R., Hitoshi, Y., Ishii, T., Sugimoto, M., Araki, S., Tominaga, A., Yamaguchi, N. and Takatsu, K., Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 1989. 170: 1415-1420.
26. Marth, T., Strober, W., Seder, R. A. and Kelsall, B. L., Regulation of transforming growth factor-beta production by interleukin-12. Eur. J. Immunol. 1997. 27:1213-1220.
27. Pape, K. A., Kearney, E. R., Khoruts, A., Mondino, A., Merica, R., Chen, Z. M., Ingulli, E., White, J., Johnson, J. G. and Jenkins, M. K., Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunol. Rev. 1997. 156: 67-78.
28. Sun, J., Dirden-Kramer, B., Ito, K., Ernst, P. B. and Van Houten, N., Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 1999. 162: 5868-5875.
29. Francois, B. J., Regulatory T cells under scrutiny. Nat. Rev. Immunol. 2003. 3: 189-198.
30. Khoruts, A., Mondino, A., Pape, K. A., Reiner, S. L. and Jenkins, M. K., A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism, J. Exp. Med. 1998. 187: 225-236.
31. Van Parijs, L., Biuckians, A., Ibragimov, A., Alt, F. W., Willerford, D. M. and Abbas, A. K., Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 1997. 158: 3738-3745.
32. + T cells. J. Immunol. 1990. 144: 3288-3295.
33. Lee, W. T. and Pelletier, W. J., Visualizing memory phenotype development after in vitro stimulation of CD4(+) T Cells. Cell. Immunol. 1998. 188: 1-11.
34. Nakamura, K., Kitani, A. and Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001. 194: 629-644.
35. + T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J. Immunol. 2000. 165: 6908-6914.
36. Chen, W., Jin, W. and Wahl, S. M., Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J. Exp. Med. 1998. 188: 1849-1857.
37. Gudmundsdottir, H., Wells, A. D. and Turka, L. A., Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 1999. 162: 5212-5223.